Leila Alland's most recent trade in Abeona Therapeutics Inc was a trade of 36,101 Common Stock done . Disclosure was reported to the exchange on Jan. 31, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Abeona Therapeutics Inc | Leila Alland | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2025 | 36,101 | 154,366 (0%) | 0% | 0 | Common Stock | |
Abeona Therapeutics Inc | Leila Alland | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Aug 2024 | 11,797 | 118,265 (0%) | 0% | 0 | Common Stock | |
Abeona Therapeutics Inc | Leila Alland | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jul 2024 | 23,611 | 106,468 (0%) | 0% | 0 | Common Stock | |
Abeona Therapeutics Inc | Leila Alland | Director | Purchase of securities on an exchange or from another person at price $ 4.71 per share. | 16 May 2024 | 11,000 | 82,857 (0%) | 0% | 4.7 | 51,799 | Common Stock |
Abeona Therapeutics Inc | Leila Alland | Director | Grant, award, or other acquisition of securities at price $ 4.62 per share. | 14 Jun 2023 | 58,689 | 79,103 (0%) | 0% | 4.6 | 271,143 | Common Stock |
PMV Pharmaceuticals Inc | Leila Alland | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 May 2023 | 100,000 | 100,000 | - | - | Employee Stock Option (right to buy) | |
Abeona Therapeutics Inc | Leila Alland | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Sep 2022 | 13,400 | 20,414 (0%) | 0% | 0 | Common Stock | |
PMV Pharmaceuticals Inc | Leila Alland | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Sep 2022 | 52,200 | 52,200 | - | 0 | Common Stock | |
PMV Pharmaceuticals Inc | Leila Alland | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 104,400 | 104,400 | - | - | Employee Stock Option (right to buy) | |
PMV Pharmaceuticals Inc | Leila Alland | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 30.25 per share. | 09 Sep 2021 | 100 | 0 | - | 30.3 | 3,025 | Common Stock |
PMV Pharmaceuticals Inc | Leila Alland | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Sep 2021 | 100 | 353,850 | - | - | Employee Stock Option (right to buy) | |
PMV Pharmaceuticals Inc | Leila Alland | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.90 per share. | 09 Sep 2021 | 100 | 100 | - | 3.9 | 390 | Common Stock |
PMV Pharmaceuticals Inc | Leila Alland | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 30.25 per share. | 07 Sep 2021 | 3,900 | 0 | - | 30.3 | 117,975 | Common Stock |
PMV Pharmaceuticals Inc | Leila Alland | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Sep 2021 | 3,900 | 353,950 | - | - | Employee Stock Option (right to buy) | |
PMV Pharmaceuticals Inc | Leila Alland | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.90 per share. | 07 Sep 2021 | 3,900 | 3,900 | - | 3.9 | 15,210 | Common Stock |
PMV Pharmaceuticals Inc | Leila Alland | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Aug 2021 | 4,000 | 357,850 | - | - | Employee Stock Option (right to buy) | |
PMV Pharmaceuticals Inc | Leila Alland | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.90 per share. | 09 Aug 2021 | 4,000 | 4,000 | - | 3.9 | 15,600 | Common Stock |
PMV Pharmaceuticals Inc | Leila Alland | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 35.06 per share. | 09 Aug 2021 | 2,198 | 1,802 | - | 35.1 | 77,070 | Common Stock |
PMV Pharmaceuticals Inc | Leila Alland | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 32.66 per share. | 09 Aug 2021 | 2,049 | 224 | - | 32.7 | 66,914 | Common Stock |
PMV Pharmaceuticals Inc | Leila Alland | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 36.69 per share. | 09 Aug 2021 | 224 | 0 | - | 36.7 | 8,219 | Common Stock |
PMV Pharmaceuticals Inc | Leila Alland | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.90 per share. | 07 Jul 2021 | 4,000 | 4,000 | - | 3.9 | 15,600 | Common Stock |
PMV Pharmaceuticals Inc | Leila Alland | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jul 2021 | 4,000 | 361,850 | - | - | Employee Stock Option (right to buy) | |
PMV Pharmaceuticals Inc | Leila Alland | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 32.66 per share. | 07 Jul 2021 | 2,049 | 0 | - | 32.7 | 66,914 | Common Stock |
PMV Pharmaceuticals Inc | Leila Alland | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 31.93 per share. | 07 Jul 2021 | 1,951 | 2,049 | - | 31.9 | 62,300 | Common Stock |
Abeona Therapeutics Inc | Leila Alland | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2021 | 98,168 | 98,168 | - | - | Stock Option (right to buy) | |
Abeona Therapeutics Inc | Leila Alland | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2021 | 77,181 | 77,181 (0%) | 0% | 0 | Common Stock | |
PMV Pharmaceuticals Inc | Leila Alland | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 May 2021 | 36,279 | 36,279 | - | - | Employee Stock Option (right to buy) | |
PMV Pharmaceuticals Inc | Leila Alland | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 May 2021 | 4,000 | 365,850 | - | - | Employee Stock Option (right to buy) | |
PMV Pharmaceuticals Inc | Leila Alland | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.90 per share. | 12 May 2021 | 4,000 | 4,000 | - | 3.9 | 15,600 | Common Stock |
PMV Pharmaceuticals Inc | Leila Alland | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 33.39 per share. | 12 May 2021 | 2,633 | 1,367 | - | 33.4 | 87,903 | Common Stock |
PMV Pharmaceuticals Inc | Leila Alland | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 34.00 per share. | 12 May 2021 | 1,367 | 0 | - | 34.0 | 46,484 | Common Stock |
PMV Pharmaceuticals Inc | Leila Alland | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 May 2021 | 4,000 | 369,850 | - | - | Employee Stock Option (right to buy) | |
PMV Pharmaceuticals Inc | Leila Alland | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.90 per share. | 07 May 2021 | 4,000 | 4,000 | - | 3.9 | 15,600 | Common Stock |
PMV Pharmaceuticals Inc | Leila Alland | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 34.80 per share. | 07 May 2021 | 3,842 | 158 | - | 34.8 | 133,702 | Common Stock |
PMV Pharmaceuticals Inc | Leila Alland | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 35.49 per share. | 07 May 2021 | 158 | 0 | - | 35.5 | 5,607 | Common Stock |
PMV Pharmaceuticals Inc | Leila Alland | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Apr 2021 | 4,000 | 373,850 | - | - | Employee Stock Option (right to buy) | |
PMV Pharmaceuticals Inc | Leila Alland | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.90 per share. | 07 Apr 2021 | 4,000 | 4,000 | - | 3.9 | 15,600 | Common Stock |
PMV Pharmaceuticals Inc | Leila Alland | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 33.86 per share. | 07 Apr 2021 | 3,972 | 28 | - | 33.9 | 134,481 | Common Stock |
PMV Pharmaceuticals Inc | Leila Alland | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 34.43 per share. | 07 Apr 2021 | 28 | 0 | - | 34.4 | 964 | Common Stock |